Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Silver Knife who wrote (799)	5/17/1999 10:44:00 PM
From: Jim Oravetz	Read Replies (1) of 2344

Sounds pretty much, IMHO, that the stock was runup today by day traders at the open(how about a quick run to 17?) then sold off pretty well. Lots of volume certainly. But hey, their name is out in print in the WSJ. That's great, the story spreads. As far as "may" vs. "does", in post Message 9575244 From a chief researcher: 'The use of immunotherapy is more likely to be successful when there is significant reduction in tumor burden,'' added Dr. Sandmaier. ''In advanced disease states, more aggressive therapy combined with therapy to stimulate the patient's own immune system MAY prove to be effective therapy.'' Looks like that are not committing to saying "it works" just yet. Until more data is presented to the FDA and others, it is still a drug in the development phase. This stock is still a BUY on my list, waiting to get some more. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next